Digital China: From cultural presence to innovative nation. This project aims to investigate how digital platforms and technologies help Chinese culture and ideas reach the world. While China's global cultural presence has increased, it is not seen as an innovative nation. The project examines how the Chinese government’s internet+ strategy changes power dynamics among political institutions, commercially motivated digital companies and online communities. The project will investigate internatio ....Digital China: From cultural presence to innovative nation. This project aims to investigate how digital platforms and technologies help Chinese culture and ideas reach the world. While China's global cultural presence has increased, it is not seen as an innovative nation. The project examines how the Chinese government’s internet+ strategy changes power dynamics among political institutions, commercially motivated digital companies and online communities. The project will investigate internationalisation strategies and consumption of Chinese culture on digital platforms in China, Australia, Hong Kong, Singapore and South Korea. It expects to understand the implications of China's digital ascendency and the lessons for Australia in the post-resources boom era.Read moreRead less
Pushing AR Toward Better Outcomes In Breast And Prostate Cancers
Funder
National Health and Medical Research Council
Funding Amount
$998,754.00
Summary
Breast and prostate cancers kill >6000 Australians each year. These cancers are strikingly similar, both driven by hormone receptors that have ‘gone bad’. Current therapies aim to eradicate the receptors. While often effective, therapeutic resistance is common and results in fatal disease. We aim to develop new, less toxic treatments that switch receptor behaviour from good to bad, without destroying them. This should improve quality of life, while preventing drug resistance and loss of lives ....Breast and prostate cancers kill >6000 Australians each year. These cancers are strikingly similar, both driven by hormone receptors that have ‘gone bad’. Current therapies aim to eradicate the receptors. While often effective, therapeutic resistance is common and results in fatal disease. We aim to develop new, less toxic treatments that switch receptor behaviour from good to bad, without destroying them. This should improve quality of life, while preventing drug resistance and loss of lives.Read moreRead less
A Randomised Controlled Trial (RCT) Of Azithromycin Versus Doxycycline For The Treatment Of Rectal Chlamydia Infection In Men Who Have Sex With Men.
Funder
National Health and Medical Research Council
Funding Amount
$797,906.00
Summary
Rectal chlamydia is very common among gay men; it can exist for long periods without symptoms leading to ongoing transmission. Azithromycin (1 gram single dose) or 7 days doxycycline (100mg twice daily) are the two recommended treatments globally. But, there is concern about rectal chlamydia treatment with reports of up to 22% failure following azithromycin. We will conduct a randomised trial to compare these treatments for rectal chlamydia and determine which drug works better.
Discovery Early Career Researcher Award - Grant ID: DE180100950
Funder
Australian Research Council
Funding Amount
$368,446.00
Summary
Building intelligence into online video services by learning user interests. This project aims to build an intelligent video streaming service by characterising users’ view interest patterns and predict user interest changes through learning data from Internet to address the challenge caused by astronomic video population. The outcomes of the project will be of great values for users and our society by intelligently filtering out valueless, harmful, illegal and unwanted videos in advance.
Early Career Industry Fellowships - Grant ID: IE230100119
Funder
Australian Research Council
Funding Amount
$427,111.00
Summary
Towards Internet of Things Enabled Automated Mushroom Cultivation. This project aims to develop novel Internet-of-Things based learning techniques to inform the design and construction of a portable, automated system for the cultivation of mushrooms. The expected outcomes are a portable smart mushroom cultivation system that provides access to new agriculture techniques and local, fresh supplies in rural and remote areas; learning algorithms that detect mushroom ripeness and set the best environ ....Towards Internet of Things Enabled Automated Mushroom Cultivation. This project aims to develop novel Internet-of-Things based learning techniques to inform the design and construction of a portable, automated system for the cultivation of mushrooms. The expected outcomes are a portable smart mushroom cultivation system that provides access to new agriculture techniques and local, fresh supplies in rural and remote areas; learning algorithms that detect mushroom ripeness and set the best environmental parameters; and a dataset of mushroom cultivation parameters. These products, and associated training opportunities through a strong focus on public and industry engagement, will benefit the industry partners and horticultural producers to improve resource efficiency, waste reduction, and overall yield.Read moreRead less
Virtual Galleries: new media technologies to influence livelihood and arts participation in remote communities of the Northern Territory, Australia. The Virtual Galleries project addresses the issue of limited economic development in remote communities by introducing a user-controlled webcam and interactive 3-D (three-dimensional) Art Galleries into remote art centres to help people in remote communities to secure an income and create wealth and social wellbeing for themselves, their families an ....Virtual Galleries: new media technologies to influence livelihood and arts participation in remote communities of the Northern Territory, Australia. The Virtual Galleries project addresses the issue of limited economic development in remote communities by introducing a user-controlled webcam and interactive 3-D (three-dimensional) Art Galleries into remote art centres to help people in remote communities to secure an income and create wealth and social wellbeing for themselves, their families and their communities.Read moreRead less
ARC Centre of Excellence in Convergent Bio-Nano Science and Technology. The CoE in Convergent Bio-Nano Science &Technology comprises a multi-disciplinary team focused on research aiming to understand and control the interface of materials with biological systems. The Centre will exploit knowledge of the bio-nano interface to design materials that transport and deliver vaccines, drugs and gene therapy agents, and to design new diagnostic agents and devices. Nanomedicines are on the cusp of revol ....ARC Centre of Excellence in Convergent Bio-Nano Science and Technology. The CoE in Convergent Bio-Nano Science &Technology comprises a multi-disciplinary team focused on research aiming to understand and control the interface of materials with biological systems. The Centre will exploit knowledge of the bio-nano interface to design materials that transport and deliver vaccines, drugs and gene therapy agents, and to design new diagnostic agents and devices. Nanomedicines are on the cusp of revolutionizing diagnosis and therapy in many diseases. The CoE will be the focus of bio-nano research activity in Australia, uniting universities, research agencies, institutes and companies. The expected outcomes are better diagnostic and therapeutic tools designed via an enhanced understanding of the bio-nano-interface.Read moreRead less
An In Depth Analysis Of Clinical And Virological Outcomes Of 2 Strategies For The Antiretroviral Salvage Of First-line Regimen Virological Failure For HIV-1 Infection Tested In An Australian-led Randomised, International, Multi-centre Clinical Trial
Funder
National Health and Medical Research Council
Funding Amount
$421,747.00
Summary
The recently completed Australian-led SECOND-LINE trial is the first high quality study to provide reliable evidence for policy recommendations for the composition of anti-HIV drug cocktails after standard initial treatment has failed. This award will support the researcher in further refining our understanding of how to manage second-line therapy including proposals to test the use of low-cost technologies for application in resource-limited settings where the majority of people with HIV live.